Medicina
Departamento
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (6.030)
2024
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767
-
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
Journal of Neuro-Oncology, Vol. 166, Núm. 3, pp. 407-415
-
A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers
CNS Neuroscience and Therapeutics, Vol. 30, Núm. 2
-
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy: the Spanish registry
Blood
-
Adult respiratory distress syndrome (ARDS) due to omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS): case report and review of the literature
Revista Espanola de Anestesiologia y Reanimacion
-
Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623
-
Are lead, cadmium and mercury risk factors for resistant hypertension?
Journal of Trace Elements in Medicine and Biology, Vol. 84
-
Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population
Journal of Endocrinological Investigation
-
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study
The Lancet Oncology, Vol. 25, Núm. 1, pp. 46-61
-
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
The Lancet Oncology, Vol. 25, Núm. 1, pp. 29-45
-
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Cancers, Vol. 16, Núm. 2
-
CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis
Cancer Letters, Vol. 588
-
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Lung Cancer, Vol. 189
-
Capacidad del biomarcador suPAR para estratificar el pronóstico en pacientes atendidos en servicios de urgencias hospitalarios
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 1, pp. 17-24
-
Cardiovascular considerations on recreational scuba diving. SEC-Clinical Cardiology Association/SEC-Working Group on Sports Cardiology consensus document
Revista Espanola de Cardiologia
-
Changes in colour perception in Alzheimer's disease continuum
Acta Ophthalmologica
-
Changes in the structure and function of the visual pathway in subjects at high risk for the development of Alzheimer's disease: 27 months of follow‐up
Acta Ophthalmologica
-
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206
-
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study
European Urology
-
Characterization of lesions produced by pulmonary vein isolation with radiofrequency balloon
Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 267-269